IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates IGM Biosciences (IGMS) delivered earnings and revenue surprises of +626.67% and +4,388.22%, respectively, for the quarter ended June 2025. Do…
Igm Biosciences CFO Tahir sells $11k in stock By Investing.com Igm Biosciences CFO Tahir sells $11k in stock…
Igm Biosciences CEO Harler sells $18k in shares By Investing.com Igm Biosciences CEO Harler sells $18k in shares…
Igm Biosciences CBO Decker sells $5611 in stock By Investing.com Igm Biosciences CBO Decker sells $5611 in stock…
IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right MOUNTAIN VIEW, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company that…
IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates IGM Biosciences (IGMS) delivered earnings and revenue surprises of -109.76% and 91.70%, respectively, for the quarter ended March 2025. Do…
IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release IGM Biosciences (IGMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…
IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit MOUNTAIN VIEW, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company…
IGM Biosciences stock surges as Biogens deal for HI-Bio is seen as a positive By Investing.com IGM Biosciences stock surges as Biogens deal for HI-Bio is seen as a positive…
IGM Biosciences refines Sanofi antibody collaboration By Investing.com IGM Biosciences refines Sanofi antibody collaboration…
IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum MOUNTAIN VIEW, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company…
IGM Biosciences executive sells over $9,000 in stock By Investing.com IGM Biosciences executive sells over $9,000 in stock…
IGM Biosciences CEO sells shares worth over $89k By Investing.com IGM Biosciences CEO sells shares worth over $89k…
IGM Biosciences executive sells over $33k in company stock By Investing.com IGM Biosciences executive sells over $33k in company stock…
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update MOUNTAIN VIEW, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company…